Epstein Secrets

information about Biden inside the United States through lobbyists, Congress, the media and contacts with figures close to the president." ODNI and the Treasury Department have "identified Derkach as a Russian agent, but it has not been publicly reported that the CIA, NSA and FBI believed Putin may be personally direct

oration "between BuzzFeed News and more than 100 newsrooms associated with the International Consortium of Investigative Journalists, shows that the US Treasury EFTA00136705 Department received at least 86 warnings from 2007 to 2016 discussing" Russian bank VEB, its clients, and Evgeny Buryakov, who was s

us Diseases Director Anthony Fauci; CDC Director Robert Redfield; Assistant Secretary of Health and Human Services for Health Adm. Brett Giroir; and Food and Drug Administration Commissioner Stephen Hahn Location: Rm G50, Dirksen Senate Office Building, Washington, DC; 10:00 AM * Senate Homeland Security and Governmental Af

sury A "Good Idea." Politico (12/7, Warmbrodt, 4.29M) reports NEC Director Kudlow on Monday "applauded [Biden's] nomination of Janet Yellen to lead the Treasury Department. ... Kudlow said Yellen's nomination to lead Treasury was a 'good idea: He said she 'knows the ropes' and did a 'decent job' when she chaired the Fe

govt, science, education, philanthropy, and technology to address health challenges facing the U.S. and the world. Day two speakers include former Food and Drug Administration Commissioners Robert Califf, Margaret Hamburg and Mark McClellan, Democratic Reps. Diana DeGette and Tim Ryan, Republican Rep. Fred Upton, World He

AM I 2172 Rayburn HOB - Host: Committee on Foreign Affairs I Subcommittee on Africa, Global Health, and Global Human Rights • Hearing: Oversight of the Treasury Department's and Federal Reserve's Pandemic Response - 10:00 AM - Host: Committee on Financial Services • Hearing: Examining the Policies and Priorities of the

ch Times (11/30, Nguyen Ly). US Panel Backs First-Of-A-Kind COVID-19 Pill From Merck The Associated Press (11/30, Perrone) reported that a panel of Food and Drug Administration (FDA) health advisers voted 13-10 in support of Merck's new COVID-19 pill, molnupiravir, stating that the antiviral drug's benefits outweigh its ri